Search Results

0 results for ''Finnegan, Henderson, Farabow, Garrett & Dunner''

You can use to get even better search results
January 20, 2023 | Law.com

Design Patent Appeal Splinters Federal Circuit Panel + Susman Scores $163M Jury Verdict + Finnegan Protects Under Armour's House

Mark Lemley's argument about design patent obviousness and the Supreme Court's KSR decision fell short of a win, but has served to raise the profile of the issue.
6 minute read
January 20, 2023 | Litigation Daily

Litigator of the Week: Standing Strong for Under Armour's Trademarks Without Going Overboard Against Upstart Armorina

Finnegan's Douglas "Chip" Rettew helped client Under Armour avoid coming off like a Goliath by asking for just $1 in damages in an infringement trial involving the company's Armour-based trademark.
10 minute read
January 13, 2023 | Law.com

Skilled in the Art With Scott Graham: The Federal Circuit's Hot Bench Isn't Cooling Down Any Time Soon + Orrick Joins Effort to Get AIs Recognized as Inventors

Judges Tiffany Cunningham and Leonard Stark started out their careers being deferential to their colleagues during oral arguments, as is often expected of junior judges. More recently they've been speaking up.
9 minute read
December 15, 2022 | Law.com

Federal Judge Rejects Finnegan Lawyers' Lanham Act Challenge for Timberland Boot Characteristics

"The saturation of the market with look-alike boots using many of the same functional features is fatal to TBL's claim that consumers look for these features to identify TBL's boots and distinguish them from competing boots," the judge wrote.
5 minute read
November 11, 2022 | The American Lawyer

The American Lawyer Names Attorney of the Year, Law Firm of the Year and More

Law Firm of the Year went to Ropes & Gray while Latham & Watkins won Law Firm Corporate Practice of the Year. Other honors included lifetime achievers, young lawyers of the year and a suite of industry awards aimed at honoring the evolution of the profession.
10 minute read
November 11, 2022 | Law.com

Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement

"We are disappointed with the jury's verdict and we remain confident that Lilly will ultimately prevail in this case," Lilly spokeswoman Daphne Dorsey told Law.com. "Importantly, this decision has no effect on our ability to make Emgality available to patients."
3 minute read
November 04, 2022 | Litigation Daily

Litigator of the Week Runners-Up and Shout Outs

Steptoe & Johnson litigators are runners-up for upholding their Chancery Court win requiring CorePower Yoga to buy 34 studios from their client Level 4 Yoga, a Corepower franchisee.
4 minute read
October 17, 2022 | Daily Report Online

In Hotel Dispute, One IHG Sues Another for Trademark Infringement

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read
October 13, 2022 | Delaware Business Court Insider

Reed Smith to Defend Commercial Seed Producer Over Patent for Breeding Maize

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read
Bial-Portela & CA. S.A. v. Alkem Lab. Ltd
Publication Date: 2022-10-04
Practice Area: Patent Litigation
Industry: Pharmaceuticals
Court: U.S. District Court of Delaware
Judge: District Judge Connolly
Attorneys:
For plaintiff: Steven J. Balick, Andrew C. Mayo, Ashby & Geddes, Wilmington, DE; James B. Monroe, Jennifer H. Roscetti, Charles T. Collins-Chase, Lauren J. Dowty, Meredith H. Boerschlein, Ryan V. McDonnell, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC; Jack B. Blumenfeld, Karen A. Jacobs, Jennifer Ying, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE for plaintiffs.
For defendant: Benjamin J. Schladweiler, Samuel L. Moultrie, Greenberg Traurig, LLP, Wilmington, DE; Aaron F. Barkoff, Alejandro Menchaca, Rajendra A. Chiplunkar, Ben J. Mahon, Ashley M. Ratycz, McAndrews, Held & Malloy, LTD., Chicago, IL for defendant.
Case number: 18-304-CFC-CJB

Court found for defendants in part in a case claiming patent infringement under 35 U.S.C. §271e(2)(A) for a new patent application for medication to treat partial-onset epileptic seizures.

TRENDING STORIES

    Resources